Canada
· Delayed Price · Currency is CAD PreveCeutical Medical Statistics
Total Valuation
PreveCeutical Medical has a market cap or net worth of CAD 8.13 million. The enterprise value is 12.32 million.
| Market Cap | 8.13M |
| Enterprise Value | 12.32M |
Important Dates
The next estimated earnings date is Thursday, November 21, 2024.
| Earnings Date | Nov 21, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PreveCeutical Medical has 541.70 million shares outstanding. The number of shares has increased by 0.96% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 541.70M |
| Shares Change (YoY) | +0.96% |
| Shares Change (QoQ) | +0.31% |
| Owned by Insiders (%) | 18.46% |
| Owned by Institutions (%) | n/a |
| Float | 441.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.78 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -36.72 |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -12.51 |
| Interest Coverage | -2.68 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -292.67% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.00% in the last 52 weeks. The beta is 0.94, so PreveCeutical Medical's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -40.00% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 51.10 |
| Average Volume (20 Days) | 86,588 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -865,017 |
| Pretax Income | -1.26M |
| Net Income | -1.26M |
| EBITDA | -855,110 |
| EBIT | -865,017 |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 234 in cash and 4.20 million in debt, giving a net cash position of -4.20 million or -0.01 per share.
| Cash & Cash Equivalents | 234 |
| Total Debt | 4.20M |
| Net Cash | -4.20M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -6.28M |
| Book Value Per Share | -0.01 |
| Working Capital | -6.34M |
Cash Flow
In the last 12 months, operating cash flow was -334,658 and capital expenditures -949, giving a free cash flow of -335,607.
| Operating Cash Flow | -334,658 |
| Capital Expenditures | -949 |
| Free Cash Flow | -335,607 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PreveCeutical Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.96% |
| Shareholder Yield | -0.96% |
| Earnings Yield | -15.68% |
| FCF Yield | -4.13% |
Stock Splits
The last stock split was on May 23, 2018. It was a forward split with a ratio of 5.
| Last Split Date | May 23, 2018 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |